Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia
BelgiumBelgiumStudy on the Effects of Ketorolac and Pregabalin in Patients Undergoing Surgery for Early Estrogen Receptor-Positive Breast Cancer
BelgiumStudy Comparing BMS-986489 with Chemotherapy to Atezolizumab with Chemotherapy for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer
BelgiumStudy on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy
BelgiumStudy on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis
BelgiumStudy on Optimizing Ceftazidime-Avibactam Dosing for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
BelgiumStudy on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease
BelgiumStudy on Psilocybin-Assisted Therapy for Patients with Severe Alcohol Use Disorder
BelgiumStudy on Methadone and Sufentanil for Pain Management After Orthopedic Surgery in Patients Without Locoregional Anesthesia
BelgiumStudy of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma
BelgiumComparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
